The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish cohort of pediatric diabetes 1987 (DCPD1987)

Acta Diabetologica

Volumn 51, Issue 3, 2014, Pages 413-420

  Broe, Rebecca ^a,b   Rasmussen, Malin Lundberg ^a,b   Frydkjaer Olsen, Ulrik ^a,b   Olsen, Birthe Susanne ^c,d   Mortensen, Henrik Bindesboel ^c,d   Peto, Tunde ^b,e   Grauslund, Jakob ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Incidence; Non proliferative diabetic retinopathy; Population based; Proliferative diabetic retinopathy; Risk factors; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; REMISSION; RETINA IMAGE; RISK FACTOR; VIBRATION SENSE; ADOLESCENT; BLOOD PRESSURE; COMPLICATION; EPIDEMIOLOGY; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; YOUNG ADULT;

EID: 84905393378     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0527-1     Document Type: Article

References (32)

1. Reichard P, Nilsson BY, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329(5):304-309. doi:10.1056/ nejm199307293290502 (Pubitemid 23210681)
2. Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (14):977-986 doi:10.1056/nejm199309303291401
3. Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341(8856):1306-1309 (Pubitemid 23148093)
4. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351(9095):28-31
5. Anonymous (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (Clinical research ed) 317 (7160):703-713
6. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J (2004) Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linkoping Diabetes Complications Study. Diabetologia 47(7):1266-1272. doi:10.1007/s00125-004-1431-6 (Pubitemid 39093322)
7. Kyto JP, Harjutsalo V, Forsblom C, Hietala K, Summanen PA, Groop PH (2011) Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 34(9):2005-2007. doi:10.2337/dc10-2391
8. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH (2003) Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26(4):1258-1264 (Pubitemid 36929282)
9. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115(11):1859-1868. doi:10.1016/j.ophtha.2008.08.023
10. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ (2006) The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55(5):1463-1469 (Pubitemid 44195388)
11. Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, Parving HH (1998) Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 21(11):2007-2015 (Pubitemid 28478309)
12. Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J (1998) Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabet Med J Br Diabet Assoc 15(10):863-869. doi:10.1002/(sici)1096-9136(199810)15:10〈863:aid-dia665〉3.0.co;2-o (Pubitemid 28451957)
13. Mortensen HB, Hartling SG, Petersen KE (1988) A nation-wide cross-sectional study of glycosylated haemoglobin in Danish children with type 1 diabetes. Diabet Med J Br Diabet Assoc 5(9):871-876
14. Mortensen HB, Marinelli K, Norgaard K, Main K, Kastrup KW, Ibsen KK, Villumsen J, Parving HH (1990) A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med J Br Diabet Assoc 7(10):887-897
15. Mortensen HB, Villumsen J, Volund A, Petersen KE, Nerup J (1992) Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med J Br Diabet Assoc 9(9):834-839
16. Mortensen HB, Hougaard P, Ibsen KK, Parving HH (1994) Relationship between blood pressure and urinary albumin excretion rate in young Danish type 1 diabetic patients: comparison to non-diabetic children. Danish Study Group of Diabetes in Childhood. Diabet Med J Br Diabet Assoc 11(2):155-161 (Pubitemid 24124920)
17. Olsen BS, Johannesen J, Sjolie AK, Borch-Johnsen K, Hougarrdss P, Thorsteinsson B, Prammingss S, Marinelli K, Mortensen HB (1999) Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med J Br Diabet Assoc 16(1):79-85 (Pubitemid 29147228)
18. Olsen BS, Sjolie A, Hougaard P, Johannesen J, Borch-Johnsen K, Marinelli K, Thorsteinsson B, Pramming S, Mortensen HB (2000) A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complicat 14(6):295-300
19. Olsen BS, Sjolie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB (2004) The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complicat 18(3):160-164. doi:10.1016/s1056-8727(03)00073-4 (Pubitemid 38622544)
20. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38(4):437-444
21. Anonymous (1985) Early Treatment Diabetic Retinopathy Study (ETDRS): Manual of Operations. U.S. Department of Commerce, National Technical Information Service
22. Anonymous (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 (5 Suppl):786-806
23. Anonymous (1991) Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 (5 Suppl):823-833
24. Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105(10):1801-1815. doi:10.1016/s0161-6420(98)91020-x (Pubitemid 28509717)
25. Grauslund J, Green A, Sjolie AK (2009) Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 52(9):1829-1835. doi:10.1007/s00125-009-1450-4
26. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102(4):520-526 (Pubitemid 14127838)
27. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39(9):1116-1124 (Pubitemid 20263324)
28. Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, Fuller JH (2001) Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 44(12):2203-2209. doi:10.1007/s001250100030 (Pubitemid 34015473)
29. Lovestam-Adrian M, Agardh CD, Torffvit O, Agardh E (2001) Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J Diabetes Complicat 15(6):287-294 (Pubitemid 33065670)
30. Janka HU, Warram JH, Rand LI, Krolewski AS (1989) Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 38(4):460-464 (Pubitemid 19105404)
31. Skrivarhaug T, Fosmark DS, Stene LC, Bangstad HJ, Sandvik L, Hanssen KF, Joner G (2006) Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. Diabetologia 49(10):2281-2290. doi:10.1007/s00125-006-0364-7 (Pubitemid 44359088)
32. Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR (1986) Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care 9(5):443-452 (Pubitemid 16008972)